Revenue ₹5,425 Cr (+15.1% YoY)
Promise tracking available after 2+ quarters of coverage.
View all executive profiles for Aarti Pharmalabs LimitedAarti Pharmalabs reported Q3 FY26 revenue of ₹5,425 crore, up 15% YoY, but EBITDA fell to ₹103 crore (down 10% YoY) a...
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.
Q3 FY26
10 Feb 2026
Revenue ₹5,425 Cr (+15.1% YoY)
Aarti Pharmalabs reported Q3 FY26 revenue of ₹5,425 crore, up 15% YoY, but EBITDA fell to ₹103 crore (down 10% YoY) and PAT dropped to ₹44 crore (down 41% YoY), reflec...
bearish
high
Scorecard starts after historical backfill
Read full analysis →
Q1 FY26
14 Aug 2025
Revenue ₹386 Cr (-30.5% YoY)
Aarti Pharmalabs reported Q1 FY26 consolidated revenue of ₹386 crore, down ~30% YoY due to Ganesh Polychem deconsolidation and a planned shutdown.
neutral
medium
Scorecard starts after historical backfill
Read full analysis →